Related Experiment Video
Updated: Feb 6, 2026

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model
Published on: July 29, 2012
Autoimmunity in Chronic Chagas Disease: A Road of Multiple Pathways to Cardiomyopathy?
Elidiana De Bona1, Kárita Cláudia Freitas Lidani1, Lorena Bavia1
1Laboratory of Molecular Immunopathology, Department of Clinical Pathology, Federal University of Paraná, Curitiba, Brazil.
Insights
Chagas disease, caused by Trypanosoma cruzi, leads to chronic Chagas cardiomyopathy. This review explores how parasite evasion and molecular mimicry may trigger autoimmune responses contributing to disease progression.
Area of Science:
- Immunology
- Infectious Diseases
- Cardiology
Background:
- Chagas disease (CD) is a neglected tropical disease caused by Trypanosoma cruzi, affecting millions globally and posing a significant public health challenge.
- Chronic infection establishes, leading to chronic Chagas cardiomyopathy (CCC) due to parasite evasion of the host immune system.
- T. cruzi persistence generates immune stimuli, causing tissue damage and inflammation, potentially involving autoimmune mechanisms.
Purpose of the Study:
- To review recent findings and hypotheses on autoimmune mechanisms in the development and progression of chronic Chagas cardiomyopathy (CCC).
Main Methods:
- This review synthesizes current literature and research hypotheses regarding the autoimmune aspects of Chagas disease progression.
- Analysis of studies investigating Trypanosoma cruzi evasion strategies and their interaction with the host immune system.
- Examination of evidence for molecular mimicry and its role in generating autoimmune responses in CD.
Main Results:
- Trypanosoma cruzi employs immune evasion strategies, allowing persistent infection and chronic inflammation.
- Molecular mimicry between parasite and host proteins may induce cross-reactivity, leading to autoimmune features like autoantibodies.
- Evidence suggests a role for autoimmunity in the clinical progression of chronic Chagas cardiomyopathy, although mechanisms remain under investigation.
Conclusions:
- Autoimmune responses, potentially triggered by parasite persistence and molecular mimicry, are implicated in the pathogenesis of chronic Chagas cardiomyopathy.
- Further research is needed to elucidate the precise mechanisms driving autoimmunity in human Chagas disease progression.
- Understanding these autoimmune pathways is crucial for developing targeted therapies for chronic Chagas cardiomyopathy.
Abstract:
Chagas disease (CD), a neglected tropical disease caused by the protozoan Trypanosoma cruzi, affects around six million individuals in Latin America. Currently, CD occurs worldwide, becoming a significant public health concern due to its silent aspect and high morbimortality rate. T. cruzi presents different escape strategies which allow its evasion from the host immune system, enabling its persistence and the establishment of chronic infection which leads to the development of chronic Chagas cardiomyopathy (CCC). The potent immune stimuli generated by T. cruzi persistence may result in tissue damage and inflammatory response. In addition, molecular mimicry between parasites molecules and host proteins may result in cross-reaction with self-molecules and consequently in autoimmune features including autoantibodies and autoreactive cells. Although controversial, there is evidence demonstrating a role for autoimmunity in the clinical progression of CCC. Nevertheless, the exact mechanism underlying the generation of an autoimmune response in human CD progression is unknown. In this review, we summarize the recent findings and hypotheses related to the autoimmune mechanisms involved in the development and progression of CCC.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Chronic Kidney Disease I: Introduction
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation

